Relfovetmab
Based on 1 Customer Validation
Relfovetmab is a monoclonal antibody and also serves as a single-chain variable fragment component for engineering chimeric antigen receptors (CAR) in modified CAR-T cells. Relfovetmab can be used in studies of cancer and immune disorders.
For research use only. We do not sell to patients.
- Purity : 99.88%
- CAS No.: 2171034-70-9
- Molecular Weight:147.94 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Isotype
Feline IgG1 kappa
Recommend Isotype Controls
Species Reactivity
Feline
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
IgG1-kappa
Application
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized Beta-NGF Protein, Human (HEK293, HY-P7660) can bind Relfovetmab. The EC50 for this effect is 35.56 ng/mL.
Chemical Information
-
CAS No. 2171034-70-9
-
Appearance Liquid
-
Molecular Weight 147.94 kDa
-
Color Colorless to light yellow
-
SMILES
[Relfovetmab]
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (254 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)